Let’s meet in Basel at the LSX RNA Leaders World Congress 2022!
The Congress brings together the leading companies developing RNA-based therapeutics and is a global platform for advancing scientific and commercial collaborations, as well as sharing the recent...
View ArticleJoin Us for the Upcoming TeaTime Webinar
We’re pleased to invite you to an exclusive webinar with our CTO and Co-founder Dr. Joanna Kowalska. Watch to learn about “Harnessing the Chemical Modifications of 5′ Cap to Boost mRNA Expression in...
View ArticleExploRNA Therapeutics at the 2022 BIO International Convention
Join us at the world’s largest event for the biotech industry #2022 BIO International Convention in San Diego (June 13-16, 2022). Let’s discuss the impact of innovative RNA modification technology on...
View ArticleExPLoRNA Therapeutics receives funding to advance its novel mRNA technology
Funding from the Bill & Melinda Gates Foundation will go toward understanding the benefits o novel cap analogs for therapeutic applications.Warsaw, December 8, 2022. ExPLoRNA Therapeutics, a...
View ArticleClik here to view.
ExploRNA at PHASE2023
Meet our CEO prof. Jacek Jemielity among other Polish innovators at the Polish Healthcare Assets Sector Event. Prof. Jemielity will take part in a panel discussing how technology invented and developed...
View ArticleClik here to view.
ExploRNA joins the Alliance for mRNA Medicines
We are happy to join forces with the industry leaders working to better mRNA medicines, increase their accessibility, and educate patients and their families about mRNA and how it works in therapies...
View ArticleAvantCap publication in JACS
We are happy to share that our most recent work has been featured in the Journal of American Chemical Society. This has been a great collaboration with University of Warsaw and we’d like to thank our...
View ArticleClik here to view.
Meet ExploRNA’s CEO at PHASE2024 in Warsaw
The Polish Healthcare Assets – Sector Event (PHASE) quickly became the Polish largest public discussion about medical biotechnology. It brings together industry leaders, venture capital, public...
View ArticleClik here to view.
Primrose Bio and ExPLoRNA Therapeutics Announce Strategic Partnership to...
San Diego, CA, USA and Warsaw, Poland – September 3, 2024 – Primrose Bio, a leading biotechnology company specializing in technologies that improve the manufacturing of next-generation therapeutics,...
View ArticleClik here to view.
ExploRNA at the Polish Embassy in Tokyo and BioJapan 2024 in Yokohama!
We are proud to announce that our Director of Business Development, Piotr Stępniak, will have the honor to speak at the Polish Embassy at a special event organised to promote Polish innovative...
View Article